Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer von Rudin, Charles M., Brahmer, Julie R., Juergens, Rosalyn A., Hann, Christine L., Ettinger, David S., Sebree, Rosa, Smith, Ruth, Aftab, Blake T., Huang, Peng, Liu, Jun O.

Volltext

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer von Juergens, Rosalyn A, Wrangle, John, Vendetti, Frank P, Murphy, Sara C, Zhao, Ming, Coleman, Barbara, Sebree, Rosa, Rodgers, Kristen, Hooker, Craig M, Franco, Noreli, Lee, Beverly, Tsai, Salina, Delgado, Igor Espinoza, Rudek, Michelle A, Belinsky, Steven A, Herman, James G, Baylin, Stephen B, Brock, Malcolm V, Rudin, Charles M

Volltext

Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Non-Squamous Non-Small Cell Lung Cancer von Rudin, Charles M., Brahmer, Julie R., Juergens, Rosalyn A., Hann, Christine L., Ettinger, David S., Sebree, Rosa, Smith, Ruth, Aftab, Blake T., Huang, Peng, Liu, Jun O.

Volltext

Abstract LB-411: A phase II study of combination epigenetic therapy in advanced non-small cell lung cancer von Juergens, Rosalyn, Vendetti, Frank, Wrangle, John, Coleman, Barbara, Sebree, Rosa, Rudek-Renaut, Michelle, Belinsky, Steven, Brock, Malcolm, Herman, James, Baylin, Stephen, Rudin, Charles

Volltext

Abstract ED03-04: Using epigenetic biomarkers as prognostic and predictive markers in non-small cell lung cancer (NSCLC) and the promise of epigenetic therapy von Brock, Malcolm V., Juergens, Rosalyn A., Wrangle, John, Vendetti, Frank P., Murphy, Sara, Zhao, Ming, Coleman, Barbara, Sebree, Rosa, Rodgers, Kristen, Hooker, Craig M., Franco, Noreli, Lee, Beverly, Tsai, Salina, Delgado, Igor Espinoza, Rudek, Michelle A., Belinsky, Steven, Herman, James G., Baylin, Stephen B., Rudin, Charles M.

Volltext